Health care diagnostics and analytics company Genalyte and Sonora Quest Laboratories announced a strategic partnership with Cigna Medicare Arizona to leverage science-based analytics to reduce costs while improving clinical outcomes for customers of Cigna Arizona’s Medicare Advantage plans.
Genalyte’s analytics approach applies both a causal and associative model of data and clinical research to stratify a population by health condition risk and clinical interventional opportunities.
Cigna’s investment in advanced analytics will empower its clinicians and care teams to engage patients in discussions about their health, chronic disease management and risks, and personalized pathways to help mitigate risk, according to the release.
Genalyte’s predictive analytics pinpoint patients who should be targeted with diagnostic and therapeutic interventions in the plan year.
"We are very excited about this partnership with Sonora Quest to enable Cigna Medicare Arizona to identify customers who will likely require clinical oversight to improve care and reduce costs," said Hossein Fakhrai-Rad, president of BaseHealth Analytics at San Diego-based Genalyte.
